Cullinan Therapeutics (CGEM) Capital Expenditures (2020 - 2025)
Cullinan Therapeutics' (CGEM) quarterly Capital Expenditures came in at $11000.0 in Q4 2025, down 77.55% quarter-over-quarter from $49000.0 in Q2 2023.
Cullinan Therapeutics (CGEM) Capital Expenditures (2020 - 2025) Analysis & Trends
Cullinan Therapeutics' Capital Expenditures history runs 4 years deep, the most recent figure standing at $11000.0 for Q4 2025.
- On a quarterly basis, Capital Expenditures changed N/A year-over-year to $11000.0 in Q4 2025; TTM through Dec 2025 was $11000.0, a N/A change from a year earlier, with the FY2025 full-year figure at $49000.0, changed N/A from the prior year.
- Capital Expenditures slipped to $11000.0 in Q4 2025 per CGEM's latest filing, from $49000.0 in the prior quarter.
- Across five years, Capital Expenditures topped out at $882000.0 in Q4 2022 and bottomed at $11000.0 in Q4 2025.
- The 3-year median for Capital Expenditures is $159000.0 (2023), against an average of $270400.0.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -8,939.03 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 43.25 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 133.40 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 230.60 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 786,000.00 |
| 10 | Cullinan Therapeutics | 368.65 Mn | 368.65 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 11,000.00 |
| Dec 31, 2025 | 11,000.00 |
| Jun 30, 2023 | 49,000.00 |
| Jun 30, 2023 | 49,000.00 |
| Mar 31, 2023 | 159,000.00 |
| Mar 31, 2023 | 159,000.00 |
| Dec 31, 2022 | 882,000.00 |
| Dec 31, 2022 | 882,000.00 |
| Sep 30, 2022 | 251,000.00 |
| Sep 30, 2022 | 251,000.00 |
| Dec 31, 2020 | -1,000.00 |
| Dec 31, 2020 | -1,000.00 |
| Sep 30, 2020 | 4,000.00 |
| Sep 30, 2020 | 4,000.00 |
| Jun 30, 2020 | 4,000.00 |
| Jun 30, 2020 | 4,000.00 |
| Mar 31, 2020 | 3,000.00 |
| Mar 31, 2020 | 3,000.00 |